In cancer cells it has been shown that mTOR activates its downstream effector 4E-BP1 and p70S6K, which subsequently leads to translation of pro-apoptotic proteins27, 52 as well as phosphorylates and inactivation of the anti-apoptotic protein Bcl-228. Here, RPS6KB1 is linked to cancer.